An overview of lncRNA GAPLINC's role in human cancer growth and metastasis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) play crucial roles in cancer development and progression.
• GAPLINC (Gastric Adenocarcinoma Predictive Long Intergenic Non-coding RNA) is frequently dysregulated in various cancers, correlating with poor prognosis.
• Existing research on GAPLINC's oncogenic functions is fragmented, necessitating a comprehensive overview.

Purpose of the Study:

• To systematically review and synthesize the current knowledge on GAPLINC's molecular mechanisms, regulatory networks, and functional roles in diverse cancer types.
• To evaluate GAPLINC's potential as a diagnostic, prognostic, and therapeutic target in oncology.
• To provide an integrated perspective and identify future research directions for GAPLINC in cancer.

Main Methods:

• Systematic literature review and analysis of existing studies on GAPLINC.
• Consolidation of findings on GAPLINC's molecular interactions (e.g., with microRNAs) and involvement in cancer-related pathways (e.g., EMT).
• Evaluation of GAPLINC's expression patterns and clinical significance across multiple cancer types.

Main Results:

• GAPLINC exhibits diverse oncogenic roles through various molecular mechanisms, including microRNA interactions and modulation of epithelial-mesenchymal transition (EMT).
• Aberrant GAPLINC expression is linked to tumor initiation, progression, and metastasis in cancers such as gastric, colorectal, NSCLC, glioma, RCC, and ESCC.
• GAPLINC demonstrates potential as a versatile biomarker for cancer diagnosis and prognosis.

Conclusions:

• GAPLINC is a significant long non-coding RNA with multifaceted roles in cancer biology.
• Understanding GAPLINC's common and cancer-specific functions is crucial for developing targeted diagnostic and therapeutic strategies.
• GAPLINC represents a promising target for future oncological research and clinical applications.